OVP Venture Partners
has led the drive into new, high-growth technology markets in the Pacific
Northwest for over 24 years. OVP’s strategy of focusing on
early stage investments in defined spaces has yielded proven results;
the firm’s record of 52 liquidity events – including 22 IPOs – leads
the region. The OVP team has a passion for working with ground-breaking
entrepreneurs and high-caliber investors, and is known for its track
record and personal integrity. OVP has over $750 million in capital
under management and is currently investing its seventh fund.
OVP has offices in Seattle and Portland and concentrates on opportunities
at the intersection of technology’s next big waves and the foundational
strengths native to the region. The firm’s recent investments
have been in communications, software, security, semiconductors, digital
biology, and nanotechnology.
The OVP team includes investing partners Chad Waite, Lucinda Stewart, Mark
Ashida, Rick LeFaivre and Carl Weissman in Seattle and Gerry Langeler,
Dave Chen and John Hull in Portland. Chad Waite serves on the Board
of the National Venture Capital Association (NVCA).
![]() |
Monitor Ventures is an early-stage venture capital firm that partners with exceptional entrepreneurs to commercialize technology into world-class products and services.
Founded in 2002, the Firm leverages the investment, operating and entrepreneurial experience of its partners with its privileged access to the resources of the Monitor Group to accelerate portfolio companies path to customers, capital and profitability.
![]() |
Life Science Angels, Inc. (LSA) is the premier angel investment group focused solely on biotechnology and medical device companies. It was established by senior life science executives and experienced angel investors to meet the need for seed and early stage funding for life science companies that is often not available from venture capitalists or individual investors. By identifying promising investment opportunities and bringing together members who add sector-specific experience, broad networks, and financial backing, Life Science Angels is able to assist emerging companies to position themselves for later-round venture-backed funding.